Monster Digital files for a $30 mln

Note: Monster Digital Inc. (ticker: MSDI), a consumer electronics company specializing in action cameras and memory products, completed its initial public offering on July 8, 2016. It raised about $11.25 million by selling 2.5 million shares at $4.50 each on the Nasdaq Capital Market. 

The company later faced financial challenges and delisted, trading over-the-counter as NMTRQ by 2016.

==========
Monster Digital's primary business focus is the design, development and marketing of premium products under the Monster Digital brand for use in high-performance consumer electronics, mobile product and computing applications.

The company has applied to list on Nasdaq under the symbol MSDI. The company has a license with Monster, Inc. which allows them to manufacture and sell certain high-end products utilizing the "Monster Digital" brand name.

Timeline of Key Events

Date/Period	Event	Impact
2014–2015	Pre-IPO revenue drops; gross margins thin (2.1% in 2014). Relies on high-cost invoice factoring ($4M facility at 15% rate + 22.5% fee).	Accumulated $21.4M deficit; H1 2015 sales decline 17% YoY to ~$10M (after $943K reserve); gross margin falls to 10% from 22%.
July 8, 2016	IPO raises $11.25M at $4.50/share on Nasdaq.	Short-term capital infusion, but stock peaks at ~$5 before declining; company warns of "net losses for the foreseeable future" and need for more financing.
Q1 2016–2017	Sales plummet 61% YoY; customer concentration issues (top 3 customers drive drop).	Quarterly revenue $2–3M; ongoing net losses ($2M/quarter); stock falls below $1, triggering Nasdaq compliance warnings.
Mid-2017	Faces Nasdaq delisting risk; trades as penny stock (<$0.50/share). Explores merger to avoid collapse.	Market cap ~$5M; EPS averages -$2.44 over 5 years; desperate cost cuts but no turnaround.
January 30, 2018	Reverse merger with Innovate Biopharmaceuticals Inc.; 1-for-10 reverse stock split. MSDI becomes shell for biotech pivot.	Core electronics ops spun off to MD Holding Co.; original business effectively ends; trades OTC as INNT (later).
Post-2018	Innovate focuses on biopharma; Monster Digital's assets liquidated or abandoned.	No revival of consumer electronics; company renamed, but legacy ops cease.